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How does methadone maintenance affect early 
mothering?
Katie Sambrooks, Emma Smith, Zelda Summers  & Pamela J Taylor  School of Medicine, Cardiff University 
and ABMU Health Board
Background
 Methadone is a synthetic opiate 
used as part of a maintenance 
programme since 1965
Method
A systematic literature review
 Searched core databases & selected 
journals
 Keywords for mother, child  & 
opiates/methadone
 4,886 titles retrieved after duplicates 
removed
 93% agreement on 100 randomly 
selected abstracts
 Data extracted and analysed 
descriptively
Inclusion criteria
 Sample: mothers on MM 
from pregnancy into post 
partum and their live 
newborns
 Study design: must 
include treatment 
comparison
 Study measures: must 
include ratings of child 
outcome (level 1) or from 
which this may be 
inferred (level 2, e.g. 
mother retains custody) 
Results
Only 4 papers were directly pertinent :
1. Wilson et al (1981):  Level 1&2 
measures.  At one year, 100% of drug-
free control, (n=58) 80% of MM (n=39) 
and 52%  of untreated drug-dependent 
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with mother; care patterns most similar 
MM and drug-free mothers
2. Fischer et al (1998):  Level 2 measures 
only. At 3 years, 100% buprenorphine
mothers (n=10), 56% MM mothers 
(n=43) and 44% slow release morphine 
mothers (n=29) still with children 
3. Fundaro et al (2002):  Level 1& 2 
measures. At 7.8 years in 94% of MM 
(n=32) and 31% untreated (n=29) cases 
children with mother in a drug free 
household
4. Simmat-Durand et al (2011):  
Retrospective cohort study of 170 
newborns 1999-2008.  Level 1 & 2 
measures.  Improvements in direct  
child measures and lowered fostering 
rates attributed to MM/similar
Our questions
 How does 
methadone 
maintenance affect 
capacity to care for 
the newborn ?
 Does it confer any 
advantages over 
other treatments?
 Is there good 
enough evidence to 
inform care and 
custody decisions?
 Rarity of study
 Probable longer-term advantage for 
children of methadone maintained mothers 
 May be because this engages mothers with 
services
 Need comprehensive services
 Maternal childhood trauma a major 
confounding factor 
